Comera Life Sciences Holdings, Inc. Quarterly Operating Income (Loss) in USD from Q2 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Comera Life Sciences Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2021 to Q3 2023.
  • Comera Life Sciences Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$2.16M, a 14.9% increase year-over-year.
  • Comera Life Sciences Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$9.15M.
  • Comera Life Sciences Holdings, Inc. annual Operating Income (Loss) for 2022 was -$12M, a 116% decline from 2021.
  • Comera Life Sciences Holdings, Inc. annual Operating Income (Loss) for 2021 was -$5.54M, a 160% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$9.15M -$2.16M +$378K +14.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$9.53M -$1.48M +$2.49M +62.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$12M -$2.5M -$47.8K -1.95% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 -$12M -$3.01M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-17
Q3 2022 -$2.54M -$1.62M -177% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$3.97M -$2.07M -109% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$2.45M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 -$914K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.9M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.